Elora Gupta
Impact in
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 4
- Angiogenesis and VEGF in Cancer 1
- Oncology 3
- Co-authors
- Viral Vyas (3 shared papers)Eric H. Rubin (3 shared papers)Jessie L.‐S. Au (1 shared paper)M. Guillaume Wientjes (1 shared paper)A. H. Cornfield (2 shared papers)Anne Lewin (1 shared paper)John Bird (1 shared paper)Joseph Fargnoli (1 shared paper)
- Journals
- Annals of the New York Academy of Sciences (2 papers)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Pharmaceutical Research (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Elora Gupta
10 papers receiving 377 citations
Peers
Comparison fields: 5 of 62
- Oncology 181
- Cancer Research 98
- Pharmaceutical Science 29
- Toxicology 13
- Immunology and Allergy 16
Countries citing papers authored by Elora Gupta
This map shows the geographic impact of Elora Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elora Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elora Gupta more than expected).
Fields of papers citing papers by Elora Gupta
This network shows the impact of papers produced by Elora Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elora Gupta. The network helps show where Elora Gupta may publish in the future.
Co-authors
The 25 scholars most cited alongside Elora Gupta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. | 2001 | 89 |
| 2 | 1999 | 55 | |
| 3 | In vitro activation of irinotecan to SN-38 by human liver and intestine. | 1999 | 50 |
| 4 | 2004 | 49 | |
| 5 | 2001 | 34 | |
| 6 | 1995 | 29 | |
| 7 | 2000 | 26 | |
| 8 | 1998 | 21 | |
| 9 | Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies. | 2002 | 21 |
| 10 | 2014 | 15 |
About Elora Gupta
Elora Gupta is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Organic Chemistry, having authored 10 papers that have together received 389 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Protease and Inhibitor Mechanisms (2 papers), Intraperitoneal and Appendiceal Malignancies (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Structural and Chemical Analysis of Organic and Inorganic Compounds (1 paper) and Cardiac Arrhythmias and Treatments (1 paper). The work is most often cited by research in Oncology (181 citations), Cancer Research (98 citations), Pharmaceutical Science (29 citations), Toxicology (13 citations) and Immunology and Allergy (16 citations). Elora Gupta has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Viral Vyas, Eric H. Rubin, Jessie L.‐S. Au, M. Guillaume Wientjes, A. H. Cornfield, Anne Lewin, John Bird, Joseph Fargnoli, Randy Talbott and Arris J. Henderson. Their work appears in journals such as Annals of the New York Academy of Sciences, Clinical Cancer Research, Journal of Clinical Oncology, Pharmaceutical Research and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.